Analysts' average 12-month price target for Jazz Pharmaceuticals plc is $280.
Get informed when a big investor buys or sells
+ Follow$240.07
29 analysts in the last 4 months
High: $322 | Low: $229
No recommendations in the last 4 months.
Jazz Pharmaceuticals plc posts a target price of $280. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
A target price of $280 for JAZZ means covering analysts, on average, see the stock 18.5% upside of $240.07 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.
Context for JAZZ's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Jazz Pharmaceuticals plc's other metric pages and overview cover the third.
Judging Jazz Pharmaceuticals plc against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $280 here, then scan peer and history charts to see if the gap is persistent.